Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)Therapy for Social Anxiety Disorder

ConditionsSocial Anxiety Disorder Social Fear

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-70

SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine

About this trial

This clinical trial aims to evaluate the efficacy and safety of transcutaneous auricular vagus nerve stimulation (taVNS) in patients with social anxiety disorder (SAD). The study addresses the following key research questions:

* Does taVNS demonstrate preliminary clinical efficacy in the treatment of SAD? * What adverse events may occur during taVNS treatment, and what is the treatment compliance of the subjects?

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

taVNS
sham-taVNS

Treatment groups

100 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Second Affiliated Hospital, Zhejiang University, School of Medicine

Lead sponsor

Source ClinicalTrials.gov